Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma 225 Lymphoma, Large B-Cell, Diffuse 160 Precursor Cell Lymphoblastic Leukemia-Lymphoma 143 Lymphoma, Non-Hodgkin 139 Hodgkin Disease 106 Burkitt Lymphoma 99 Lymphoma, Follicular 85 Leukemia 82 Lymphoma, Mantle-Cell 76 Lymphoma, Large-Cell, Immunoblastic 68 Leukemia, Lymphocytic, Chronic, B-Cell 56 Lymphoma, B-Cell, Marginal Zone 43 Leukemia, Myeloid, Acute 34 Recurrence 31 Lymphoma, B-Cell 31 Lymphoma, Large-Cell, Anaplastic 30 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 29 Dendritic Cell Sarcoma, Interdigitating 29 Lymphoma, Extranodal NK-T-Cell 26 Multiple Myeloma 24 Waldenstrom Macroglobulinemia 22 Myelodysplastic Syndromes 22 Lymphoma, T-Cell, Peripheral 22 Lymphoma, T-Cell, Cutaneous 20 Blast Crisis 19 Lymphoma, T-Cell 18 Leukemia, Myeloid, Accelerated Phase 18 Immunoblastic Lymphadenopathy 18 Congenital Abnormalities 18 Neoplasms, Plasma Cell 16

Interventions

midostaurin 2 selinexor 1 pegfilgrastim 1 glofitamab 1 Topotecan 1 Rituximab 1 Prednisone 1 Positron Emission Tomography Computed Tomography 1 Paclitaxel 1 Methylprednisolone 1 Immunologic Techniques 1 Ifosfamide 1 Flow Cytometry 1 Etoposide 1 Dexamethasone 1 Clofarabine 1 Carboplatin 1 Alemtuzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Aggression × Etoposide × Lymphoid × Clear all

NCT02471911 2022-04-12

KPT-330+RICE

Weill Medical College of Cornell University

Phase 1 Completed

Aggression, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon ⚡